SYSTEMETRIC

Live / Registered — Registered — partial invalidation of extension of protection (as of 01 May 2022)

What this means for you

Registered since 21 Jul 2015. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79149152
Registration number
4774665
Mark type
Stylized text
Filed
29 Apr 2014
Published for opposition
05 May 2015
Registered
21 Jul 2015
Attorney of record
Jeffrey A. Smith

Goods and services

  • Class 005 — Pharmaceuticals: [ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]
  • Class 009 — Scientific and electric apparatus: [ Scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; Laboratory apparatus and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes ]
  • Class 042 — Scientific and technological services: Scientific research and development; scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services [ and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] pharmaceutical research and development; Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]

Owner

Prosecution history

  • 20 Jan 2026 — TEAS SECTION 71 RECEIVED
  • 21 Jul 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
  • 04 Apr 2024 — INTERNATIONAL REGISTRATION RENEWED
  • 07 Jun 2023 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
  • 28 Mar 2023 — PARTIAL INVALIDATION PROCESSED BY THE IB
  • 27 Mar 2023 — LIMITATION OF GOODS RECEIVED FROM IB
  • 22 Feb 2023 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 22 Feb 2023 — INVALIDATION PROCESSED
  • 01 Jan 2023 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 01 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
  • 01 May 2022 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
  • 07 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 16 Feb 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 21 Jul 2021 — TEAS SECTION 71 & 15 RECEIVED
  • 21 Jul 2020 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

View this trademark record on Marksy